Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment
Maria Gabriella Santamaria(University of Perugia), Giovan Battista Ambrosio(Ospedale San Paolo), Paolo Prandoni(University of Padua), Giuliana Guazzaloca(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Maria Rita Taliani(University of Perugia), Adriano Bertoldi(Ospedale Santa Chiara), Walter Ageno(University of Padua), Cristina Tomasi(Ospedale di Bolzano), Marco Moia(Ospedale Maggiore), Giancarlo Agnelli(University of Perugia), Mario Bazzan(Ospedale San Giovanni Bosco), Mauro Silingardi(Ospedale Maggiore Carlo Alberto Pizzardi)
Cited by 54
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Oral Anticoagulant Therapy
|CHEST Journal|2012|1.5k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k